Company intelligence / Profile preview
Lympharma
Jerusalem, Israellympharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Lympharma was a biotechnology company focused on the development of specialized drug delivery systems targeting the lymphatic system. Based in Israel, the company utilized a proprietary liposomal platform designed to enhance the transport of therapeutic agents through lymphatic vessels, which is critical for treating metastatic cancer and various autoimmune disorders. Their technology aimed to improve the bioavailability and efficacy of drugs that are otherwise poorly absorbed or rapidly cleared from the systemic circulation. Although the company made significant strides in pre-clinical research, it is currently considered inactive.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Lipid nanoparticle delivery therapySmall moleculeNanoparticle
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Lympharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lympharma.